Detection of human leukocyte antigen loss of heterozygosity

    公开(公告)号:US11475978B2

    公开(公告)日:2022-10-18

    申请号:US17304940

    申请日:2021-06-28

    申请人: TEMPUS LABS, INC.

    IPC分类号: G16B20/10 G16B30/10 G16B40/00

    摘要: Processes are provided for detecting loss of heterozygosity of Human Leukocyte Antigen (HLA) in a subject using analysis of next generation sequencing (NGS) data. The processes include aligning NGS data and identifying unmapped and mapped reads, updating reference data, and feeding one or more sequence reads to an HLA typing process for identifying candidate HLA alleles and feeding HLA type data to a loss of heterozygosity (LOH) modeling process for determining a LOH status for each HLA allele. A report may be generated of the LOH statuses for each of HLA allele.

    METHODS AND SYSTEMS FOR DETECTING MICROSATELLITE INSTABILITY OF A CANCER IN A LIQUID BIOPSY ASSAY

    公开(公告)号:US20210098078A1

    公开(公告)日:2021-04-01

    申请号:US16945588

    申请日:2020-07-31

    申请人: Tempus Labs, Inc.

    IPC分类号: G16B30/10 G16B40/00

    摘要: Methods, systems, and software are provided for determining a microsatellite instability (MSI) status of a subject. Nucleotide sequences are obtained for cell-free DNA molecules from a liquid biopsy sample of the subject. The nucleotide sequences are used to determine, for each respective microsatellite locus in a plurality of predetermined microsatellite loci, one or more independent corresponding metrics, where each metric in the one or more metrics is determined at least in part by the distribution of the number of repeat units at the respective microsatellite locus. The one or more metrics are input into a classifier trained to distinguish between stable and unstable microsatellite loci, in order to classify the MSI status of the subject. In certain aspects, microsatellite stability metrics are compared against metrics from solid tumor samples and/or normal tissues. In certain aspects, the microsatellite stability metrics are determined relative to a subject-specific standard for microsatellite stability.

    Detection of Human Leukocyte Antigen Loss of Heterozygosity

    公开(公告)号:US20210327536A1

    公开(公告)日:2021-10-21

    申请号:US17304940

    申请日:2021-06-28

    申请人: TEMPUS LABS, INC.

    IPC分类号: G16B20/10 G16B40/00 G16B30/10

    摘要: Processes are provided for detecting loss of heterozygosity of Human Leukocyte Antigen (HLA) in a subject using analysis of next generation sequencing (NGS) data. The processes include aligning NGS data and identifying unmapped and mapped reads, updating reference data, and feeding one or more sequence reads to an HLA typing process for identifying candidate HLA alleles and feeding HLA type data to a loss of heterozygosity (LOH) modeling process for determining a LOH status for each HLA allele. A report may be generated of the LOH statuses for each of HLA allele.

    Detection of Human Leukocyte Antigen Loss of Heterozygosity

    公开(公告)号:US20230154563A1

    公开(公告)日:2023-05-18

    申请号:US17968509

    申请日:2022-10-18

    申请人: TEMPUS LABS, INC.

    IPC分类号: G16B20/10 G16B30/10 G16B40/00

    CPC分类号: G16B20/10 G16B30/10 G16B40/00

    摘要: Processes are provided for detecting loss of heterozygosity of Human Leukocyte Antigen (HLA) in a subject using analysis of next generation sequencing (NGS) data. The processes include aligning NGS data and identifying unmapped and mapped reads, updating reference data, and feeding one or more sequence reads to an HLA typing process for identifying candidate HLA alleles and feeding HLA type data to a loss of heterozygosity (LOH) modeling process for determining a LOH status for each HLA allele. A report may be generated of the LOH statuses for each of HLA allele.

    Detection of Genetic Variants in Human Leukocyte Antigen Genes

    公开(公告)号:US20230064530A1

    公开(公告)日:2023-03-02

    申请号:US17816345

    申请日:2022-07-29

    申请人: TEMPUS LABS, INC.

    IPC分类号: G16B20/00 G16B40/20 G06N20/00

    摘要: Processes are provided for identifying somatic variants in a human leukocyte antigen (HLA) gene in a subject using analysis of next generation sequencing (NGS) data. The processes include aligning HLA sequence read data for normal samples and the HLA sequence data for a tumor sample to a patient specific HLA reference genome and performing a variant calling process on filtered aligned read data and determining somatic variants of the HLA class. A report may be generated of somatic variants of the HLA gene annotated for functional effect.

    Detection of human leukocyte antigen loss of heterozygosity

    公开(公告)号:US11081210B2

    公开(公告)日:2021-08-03

    申请号:US16789413

    申请日:2020-02-12

    申请人: TEMPUS LABS, INC.

    发明人: Jason Perera

    摘要: Processes are provided for detecting loss of heterozygosity of Human Leukocyte Antigen (HLA) in a subject using analysis of next generation sequencing (NGS) data. The processes include aligning NGS data and identifying unmapped and mapped reads, updating reference data, and feeding one or more sequence reads to an HLA typing process for identifying candidate HLA alleles and feeding HLA type data to a loss of heterozygosity (LOH) modeling process for determining a LOH status for each HLA allele. A report may be generated of the LOH statuses for each of HLA allele.

    DETECTION OF HUMAN LEUKOCYTE ANTIGEN LOSS OF HETEROZYGOSITY

    公开(公告)号:US20200258597A1

    公开(公告)日:2020-08-13

    申请号:US16789413

    申请日:2020-02-12

    申请人: TEMPUS LABS, INC.

    发明人: Jason Perera

    摘要: Processes are provided for detecting loss of heterozygosity of Human Leukocyte Antigen (HLA) in a subject using analysis of next generation sequencing (NGS) data. The processes include aligning NGS data and identifying unmapped and mapped reads, updating reference data, and feeding one or more sequence reads to an HLA typing process for identifying candidate HLA alleles and feeding HLA type data to a loss of heterozygosity (LOH) modeling process for determining a LOH status for each HLA allele. A report may be generated of the LOH statuses for each of HLA allele.